drugset / Trial / NCT00237471
Impact of Tight Glycaemic Control in Acute Myocardial Infarction
Phase 4
Terminated
40 enrolled
Melbourne Health
Bristol-Myers Squibb · collabNational Health and Medical Research Council, Australia · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine whether tight glycaemic control with insulin improves myocardial function and myocardial perfusion (measured by myocardial contrast echocardiography) and novel vascular risk factors in patients with acute myocardial infarction and hyperglycaemia.
Timeline
- Start
- 2005-10
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Other |